SEC 13F Intelligence

M28 Capital Management LP / SWTXUSD

M28 Capital Management LP’s Springworks Therapeutics Inc Position

Does M28 Capital Management LP own Springworks Therapeutics Inc (SWTXUSD)? Not currently — the last reported position was 55.2K shares worth $2M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q1 2025
Shares
55.2K
% of Portfolio
+3.34%
Quarters Held
10
position exited

Position History SWTXUSD

Reported value by quarter
Q4 ’22: $3MQ4 ’22Q1 ’23: $5MQ2 ’23: $5MQ2 ’23Q3 ’23: $5MQ4 ’23: $5MQ4 ’23Q1 ’24: $5MQ2 ’24: $4MQ2 ’24Q3 ’24: $4MQ4 ’24: $4MQ4 ’24Q1 ’25: $2Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202555.2K$2M+3.34%
Q4 2024110.4K$4M+3.92%
Q3 2024110.4K$4M+3.89%
Q2 2024110.4K$4M+5.39%
Q1 2024110.4K$5M+4.02%
Q4 2023142.8K$5M+4.32%
Q3 2023197.7K$5M+5.24%
Q2 2023197.7K$5M+6.85%
Q1 2023197.7K$5M+5.75%
Q4 2022109.9K$3M+2.72%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See M28 Capital Management LP’s full portfolio or all institutional holders of SWTXUSD.